DOI QR코드

DOI QR Code

Development of High Intensity Focused Ultrasound (HIFU) Mediated AuNP-liposomal Nanomedicine and Evaluation with PET Imaging

  • Ji Yoon Kim (Department of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Un Chul Shin (School of Health and Environmental Science College of Health Science, Korea University) ;
  • Ji Yong Park (Department of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Ran Ji Yoo (Department of Nuclear Medicine, Seoul National University Hospital, College of Medicine) ;
  • Soeku Bae (School of Health and Environmental Science College of Health Science, Korea University) ;
  • Tae Hyeon Choi (Department of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Kyuwan Kim (Department of Nuclear Medicine, Seoul National University Hospital, College of Medicine) ;
  • Young Chan Ann (Department of Nuclear Medicine, Seoul National University Hospital, College of Medicine) ;
  • Jin Sil Kim (Department of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Yu Jin Shin (Department of Nuclear Medicine, Seoul National University Hospital, College of Medicine) ;
  • Hokyu Lee (Research Professor, Medical Device Innovation Center, Korea University) ;
  • Yong Jin Lee (Division of Applied RI, Korea Institute of Radiological and Medical Sciences (KIRAMS)) ;
  • Kyo Chul Lee (Division of Applied RI, Korea Institute of Radiological and Medical Sciences (KIRAMS)) ;
  • Suhng Wook Kim (School of Health and Environmental Science College of Health Science, Korea University) ;
  • Yun-Sang Lee (Department of Nuclear Medicine, Seoul National University College of Medicine)
  • Received : 2023.06.08
  • Accepted : 2023.06.20
  • Published : 2023.06.30

Abstract

Liposomes as drug delivery system have proved useful carrier for various disease, including cancer. In addition, perfluorocarbon cored microbubbles are utilized in conjunction with high-intensity focused-ultrasound (HIFU) to enable simultaneous diagnosis and treatment. However, microbubbles generally exhibit lower drug loading efficiency, so the need for the development of a novel liposome-based drug delivery material that can efficiently load and deliver drugs to targeted areas via HIFU. This study aims to develop a liposome-based drug delivery material by introducing a substance that can burst liposomes using ultrasound energy and confirm the ability to target tumors using PET imaging. Liposomes (Lipo-DOX, Lipo-DOX-Au, Lipo-DOX-Au-RGD) were synthesized with gold nanoparticles using an avidin-biotin bond, and doxorubicin was mounted inside by pH gradient method. The size distribution was measured by DLS, and encapsulation efficiency of doxorubicin was analyzed by UV-vis spectrometer. The target specificity and cytotoxicity of liposomes were assessed in vitro by glioblastoma U87mg cells to HIFU treatment and analyzed using CCK-8 assay, and fluorescence microscopy at 6-hour intervals for up to 24 hours. For the in vivo study, U87mg model mouse were injected intravenously with 1.48 MBq of 64Cu-labeled Lipo-DOX-Au and Lipo-DOX-Au-RGD, and PET images were taken at 0, 2, 4, 8, and 24 hours. As a result, the size of liposomes was 108.3 ± 5.0 nm at Lipo-DOX-Au and 94.1 ± 12.2 nm at Lipo-DOX-Au-RGD, and it was observed that doxorubicin was mounted inside the liposome up to 52%. After 6 hours of HIFU treatment, the viability of U87mg cells treated with Lipo-DOX-Au decreased by around 20% compared to Lipo-DOX, and Lipo-DOX-Au-RGD had a higher uptake rate than Lipo-DOX. In vivo study using PET images, it was confirmed that 64Cu-Lipo-DOX-Au-RGD was taken up into the tumor immediately after injection and maintained for up to 4 hours. In this study, drugs released from liposomes-gold nanoparticles via ultrasound and RGD targeting were confirmed by non-invasive imaging. In cell-level experiments, HIFU treatment of gold nanoparticle-coupled liposomes significantly decreased tumor survival, while RGD-liposomes exhibited high tumor targeting and rapid release in vivo imaging. It is expected that the combination of these models with ultrasound is served as an effective drug delivery material with therapeutic outcomes.

Keywords

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin 2019;69(1):7-34. https://doi.org/10.3322/caac.21551
  2. Brigger I, Duberne C, Couvreur P. Nanoparticles in cancer therapy and diagnosis.Adv Drug Deliv Rev 2012;64: 24-36. https://doi.org/10.1016/j.addr.2012.09.006
  3. Wang K, Lu J, Li J, Gao Y, Mao Y, Zhao Q, Wang S. Current trends in smart mesoporous silica-based nanovehicles for photoactivated cancer therapy. J Control Release 2021;339:445-72. https://doi.org/10.1016/j.jconrel.2021.10.005
  4. Xu J, Vilanova G, Gomez H. A mathematical model coupling tumor growth and angiogenesis.PloS one 2016;11(2):e0149422.
  5. Urruticoechea A, Alemany R, Balart J, Villanueva A, Vinals F, Capella G. Recent advances in cancer therapy: an overview. Curr Pharm Des 2010;16(1):3-10 https://doi.org/10.2174/138161210789941847
  6. Olusanya TOB, Haj Ahmad RR, Ibegbu DM, Smith JR, Elkordy AA. Liposomal Drug Delivery Systems and Anticancer Drugs. Molecules 2018;23(4).
  7. Lan S, Liu Y, Shi K, Ma D. Acetal-Functionalized Pillar[5]arene: A pH-Responsive and Versatile Nanomaterial for the Delivery of Chemotherapeutic Agents.ACS Appl Bio Mater 2020;3(4):2325-33. https://doi.org/10.1021/acsabm.0c00086
  8. Yamashita T, Yamashita K, Nabeshi H, Yoshikawa T, Yoshioka Y, Tsunoda SI, Tsutsumi Y. Carbon Nanomaterials: Efficacy and Safety for Nanomedicine. Materials (Basel) 2012;5(2):350-63. https://doi.org/10.3390/ma5020350
  9. Narayanan NK, Nargi D, Randolph C, Narayanan BA. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 2009;125(1):1-8. https://doi.org/10.1002/ijc.24336
  10. Paini M, Daly SR, Aliakbarian B, Fathi A, Tehrany EA, Perego P, Dehghani F, Valtchev P. An efficient liposome based method for antioxidants encapsulation. Colloids Surf B Biointerfaces 2015;136:1067-72. https://doi.org/10.1016/j.colsurfb.2015.10.038
  11. Zylberberg C, Matosevic S. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape. Drug Deliv 2016;23(9):3319-29. https://doi.org/10.1080/10717544.2016.1177136
  12. Huang Z, Li X, Zhang T, Song Y, She Z, Li J, Deng Y. Progress involving new techniques for liposome preparation.Asian J Pharm Sci 2014;9(4):176-182. https://doi.org/10.1016/j.ajps.2014.06.001
  13. Dua JS, Rana AC, Bhandari AK. Liposome: methods of preparation and applications.Int J Pharm Stud Res 2012;3(2):14-20.
  14. Gruner SM, Lenk RP, Janoff AS, Ostro MJ. Novel multilayered lipid vesicles: comparison of physical characteristics of multilamellar liposomes and stable plurilamellar vesicles. Biochemistry 1985;24(12):2833-42. https://doi.org/10.1021/bi00333a004
  15. Jensen MB, Bhatia VK, Jao CC, Rasmussen JE, Pedersen SL, Jensen KJ, Langen R, Stamou D. Membrane curvature sensing by amphipathic helices: a single liposome study using alpha-synuclein and annexin B12. J Biol Chem 2011;286(49):42603-14. https://doi.org/10.1074/jbc.M111.271130
  16. Mikhaylova M, Stasinopoulos I, Kato Y, Artemov D, Bhujwalla ZM. Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.Cancer Gene Ther 2009;16(3):217-26. https://doi.org/10.1038/cgt.2008.79
  17. Cattel L, Ceruti M, Dosio F. From conventional to stealth liposomes: a new Frontier in cancer chemotherapy. J Chemother 2004;16 Suppl 4:94-7. https://doi.org/10.1179/joc.2004.16.Supplement-1.94
  18. Solomon R, Gabizon AA. Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal doxorubicin. Leukemia 2018;8(1):21-32. https://doi.org/10.3816/CLM.2008.n.001
  19. Noble GT, Stefanick JF, Ashley JD, Kiziltepe T, Bilgicer B. Ligand-targeted liposome design: challenges and fundamental considerations. Trends Biotechnol 2014;32(1):32-45. https://doi.org/10.1016/j.tibtech.2013.09.007
  20. Tagami T, Foltz WD, Ernsting MJ, Lee CM, Tannock IF, May JP, Li S-D. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. Biomaterials 2011;32(27):6570-8. https://doi.org/10.1016/j.biomaterials.2011.05.029
  21. Park SM, Kim MS, Park SJ, Park ES, Choi KS, Kim YS, Kim HR. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU). J Control Release 2013;170(3):373-9. https://doi.org/10.1016/j.jconrel.2013.06.003
  22. Grull H, Langereis S. Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. J Control Release 2012;161(2):317-327. https://doi.org/10.1016/j.jconrel.2012.04.041
  23. Jensen CR, Ritchie RW, Gyongy M, Collin JR, Leslie T, Coussios CC. Spatiotemporal monitoring of high-intensity focused ultrasound therapy with passive acoustic mapping.Radiology 2012;262(1):252-61. https://doi.org/10.1148/radiol.11110670
  24. Murat FJ, Poissonnier L, Rabilloud M, Belot A, Bouvier R, Rouviere O, Chapelon J-Y, Gelet A. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.Eur Urol 2009;55(3):640-7. https://doi.org/10.1016/j.eururo.2008.04.091
  25. Han H, Lee H, Kim K, Kim H. Effect of high intensity focused ultrasound (HIFU) in conjunction with a nanomedicines-microbubble complex for enhanced drug delivery. J Control Release 2017;266:75-86. https://doi.org/10.1016/j.jconrel.2017.09.022
  26. You Y, Wang Z, Ran H, Zheng Y, Wang D, Xu J, Wang Z, Chen Y, Li P. Nanoparticle-enhanced synergistic HIFU ablation and transarterial chemoembolization for efficient cancer therapy. Nanoscale 2016;8(7):4324-39. https://doi.org/10.1039/C5NR08292G
  27. Qiu L, Jing N, Jin Y. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method.Int J Pharm 2008;361(1-2):56-63. https://doi.org/10.1016/j.ijpharm.2008.05.010
  28. D'Agata R, Palladino P, Spoto G. Streptavidin-coated gold nanoparticles: critical role of oligonucleotides on stability and fractal aggregation. Beilstein J Nanotechnol 2017;8:1-11. https://doi.org/10.3762/bjnano.8.1